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I
n 1998, a 39-year old patient underwent left breast mastectomy due to infiltrative ductal
carcinoma. After surgery, the tumor was staged as T2 N0 M0. At that time, neither hor-
monal status was established nor was any therapy applied. In the beginning of 2005, mul-
tiple metastases in liver were found by a chance ultrasound examination of abdomen; the
presence of metastases was also confirmed by MRI examination of the liver (Figure 1). ER,
PR, and EGFR expression was defined by immunohistochemical analyses of the tumor.
The obtained results indicated the application of chemotherapy according to CMF regimen
and targeted therapy with monoclonal antibody - cetuximab (Erbitux¤). After 4 months, the
patient was examined by MRI and the findings showed significant reduction of the number
and size of metastases in liver segments 6 and 8, mainly in the subcapsular region of the
liver (Figure 1).
Figure 1. Liver metastases in breast cancer: A. Before treatment (postagadolinium contrast, T1W), B. Before treatment (T1W, haste), C. After treatment (T1W)